Committee opinion No. 606: Options for prevention and management of heavy menstrual bleeding in adolescent patients undergoing cancer treatment

Obstetrics and Gynecology

Volumn 124, Issue 2 PART1, 2014, Pages 397-402

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; CONTRACEPTION; CONTRACEPTIVES, ORAL, COMBINED; CONTRACEPTIVES, ORAL, HORMONAL; EMERGENCIES; FEMALE; FERTILITY PRESERVATION; GONADOTROPIN-RELEASING HORMONE; HUMANS; INTERDISCIPLINARY COMMUNICATION; MENORRHAGIA; NEOPLASMS; PROGESTINS; UTERINE HEMORRHAGE;

EID: 84905024555     PISSN: 00297844     EISSN: 1873233X     Source Type: Journal    
DOI: 10.1097/01.AOG.0000452745.44206.c3     Document Type: Review

References (34)

1. Howlader N, Noone AM, Krapcho M, Garshell J, Neyman N, Altekruse SF, et al. SEER cancer statistics review, 1975-2010. Bethesda (MD): National Cancer Institute; 2013. Available at: http://seer.cancer.gov/csr/1975-2010. Retrieved March 26, 2014.
2. Miller L, Hughes JP. Continuous combination oral contraceptive pills to eliminate withdrawal bleeding: a randomized trial. Obstet Gynecol 2003;101:653-61. [PubMed] [Obstetrics & Gynecology]
3. U S. Medical Eligibility Criteria for Contraceptive Use, 2010. Centers for Disease Control and Prevention (CDC). MMWR Recomm Rep 2010; 59(RR-4): 1-86. [PubMed] [Full Text]
4. Amsterdam A, Jakubowski A, Castro-Malaspina H, Baxi E, Kauff N, Krychman M, et al. Treatment of menorrhagia in women undergoing hematopoietic stem cell transplantation. Bone Marrow Transplant 2004;34:363-6. [PubMed] [Full Text]
5. Kline RM, Fennewald L, Vore M, Bertolone SJ, Hente ML. Oral contraceptives: a cause of hyperbilirubinemia in stem cell transplant patients. J Pediatr Hematol Oncol 1999; 21:436-40. [PubMed]
6. Hagglund H, Remberger M, Klaesson S, Lonnqvist B, Ljungman P, Ringden O. Norethisterone treatment, a major risk-factor for veno-occlusive disease in the liver after allogeneic bone marrow transplantation. Blood 1998;92: 4568-72. [PubMed] [Full Text]
7. Sica S, Salutari P, Chiusolo P, Cicconi S, Sora F, Laurenti L, et al. Hormonal therapy after stem cell transplantation and risk of veno-occlusive disease. Blood 1999;93:3154. [PubMed] [Full Text]
8. Milroy CL, Jones KP. Gynecologic care in hematopoietic stem cell transplant patients: a review. Obstet Gynecol Surv 2010;65:668-79. [PubMed]
9. Raymond EG. Progestin-only pills. In: Hatcher RA, Trussell J, Nelson AL, Cates W Jr, Kowal D, Policar MS, editors. Contraceptive technology. 20th ed. New York (NY): Ardent Media; 2011. p. 237-47.
10. Hubacher D, Lopez L, Steiner MJ, Dorflinger L. Menstrual pattern changes from levonorgestrel subdermal implants and DMPA: systematic review and evidence-based comparisons. Contraception 2009;80:113-8. [PubMed] [Full Text]
11. Menstrual manipulation for adolescents with disabilities. ACOG Committee Opinion No. 448. American College of Obstetricians and Gynecologists. Obstet Gynecol 2009;114:1428-31. [PubMed] [Obstetrics & Gynecology]
12. Meirow D, Rabinovici J, Katz D, Or R, Shufaro Y, BenYehuda D. Prevention of severe menorrhagia in oncology patients with treatment-induced thrombocytopenia by luteinizing hormone-releasing hormone agonist and depo-medroxyprogesterone acetate [published erratum appears in Cancer 2007;110:936]. Cancer 2006;107:1634-41. [PubMed] [Full Text]
13. Quaas AM, Ginsburg ES. Prevention and treatment of uterine bleeding in hematologic malignancy. Eur J Obstet Gynecol Reprod Biol 2007;134:3-8. [PubMed] [Full Text]
14. Lethaby A, Cooke I, Rees MC. Progesterone or progestogen-releasing intrauterine systems for heavy menstrual bleeding. Cochrane Database of Systematic Reviews 2005, Issue 4. Art. No.: CD002126. DOI: 10.1002/14651858. CD002126.pub2. [PubMed] [Full Text]
15. Irvine GA, Campbell-Brown MB, Lumsden MA, Heikkila A, Walker JJ, Cameron IT. Randomised comparative trial of the levonorgestrel intrauterine system and norethister-one for treatment of idiopathic menorrhagia. Br J Obstet Gynaecol 1998;105:592-8. [PubMed]
16. Hidalgo M, Bahamondes L, Perrotti M, Diaz J, Dantas-Monteiro C, Petta C. Bleeding patterns and clinical performance of the levonorgestrel-releasing intrauterine system (Mirena) up to two years. Contraception 2002;65:129-32. [PubMed] [Full Text]
17. Darney P, Patel A, Rosen K, Shapiro LS, Kaunitz AM. Safety and efficacy of a single-rod etonogestrel implant (Implanon): results from 11 international clinical trials. Fertil Steril 2009;91:1646-53. [PubMed] [Full Text]
18. Bedaiwy MA, Mousa NA, Casper RF. Aromatase inhibitors prevent the estrogen rise associated with the flare effect of gonadotropins in patients treated with GnRH agonists. Fertil Steril 2009;91:1574-7. [PubMed] [Full Text]
19. Ghalie R, Porter C, Radwanska E, Fitzsimmons W, Richman C, Kaizer H. Prevention of hypermenorrhea with leuprolide in premenopausal women undergoing bone marrow transplantation. Am J Hematol 1993;42:350-3. [PubMed]
20. Laufer MR, Townsend NL, Parsons KE, Brody KA, Diller LR, Emans SJ, et al. Inducing amenorrhea during bone marrow transplantation. A pilot study of leuprolide acetate. J Reprod Med 1997;42:537-41. [PubMed]
21. Barton S, Laufer MR. Gynecologic and fertility issues for cancer patients/survivors. In: Emans SJ, Laufer MR, editors. Emans, Laufer, Goldstein's pediatric and adolescent gyne-cology. 6th ed. Philadelphia (PA): Wolters Kluwer Health/Lippincott Williams & Wilkins; 2012. p. 511-22.
22. Chiusolo P, Salutari P, Sica S, Scirpa P, Laurenti L, Piccirillo N, et al. Luteinizing hormone-releasing hormone analogue: leuprorelin acetate for the prevention of menstrual bleeding in premenopausal women undergoing stem cell transplantation. Bone Marrow Transplant 1998;21:821-3. [PubMed] [Full Text]
23. Lhomme C, Brault P, Bourhis JH, Pautier P, Dohollou N, Dietrich PY, et al. Prevention of menstruation with leu-prorelin (GnRH agonist) in women undergoing myelo-suppressive chemotherapy or radiochemotherapy for hematological malignancies: a pilot study. Leuk Lymphoma 2001;42:1033-41. [PubMed] [Full Text]
24. Kim SS, Lee JR, Jee BC, Suh CS, Kim SH, Ting A, et al. Use of hormonal protection for chemotherapy-induced gonadotoxicity. Clin Obstet Gynecol 2010;53:740-52. [PubMed]
25. Gynecologic concerns in children and adolescents with cancer. Committee Opinion No. 607. Obstet Gynecol 2014; 124:403-8.
26. Divasta AD, Laufer MR, Gordon CM. Bone density in adolescents treated with a GnRH agonist and add-back therapy for endometriosis. J Pediatr Adolesc Gynecol 2007;20: 293-7. [PubMed] [Full Text]
27. Hornstein MD, Surrey ES, Weisberg GW, Casino LA. Leuprolide acetate depot and hormonal add-back in endometriosis: a 12-month study. Lupron Add-Back Study Group. Obstet Gynecol 1998;91:16-24. [PubMed] [Obstetrics & Gynecology]
28. Levens ED, Scheinberg P, DeCherney AH. Severe menor-rhagia associated with thrombocytopenia. Obstet Gynecol 2007;110:913-7. [PubMed] [Obstetrics & Gynecology]
29. DeVore GR, Owens O, Kase N. Use of intravenous Premarin in the treatment of dysfunctional uterine bleeding-a double-blind randomized control study. Obstet Gynecol 1982;59:285-91. [PubMed] [Obstetrics & Gynecology]
30. Ferring Pharmaceuticals Inc. Lysteda™ (tranexamic acid) tablets: highlights of prescribing information. Parsippany (NJ): Ferring Pharmaceuticals Inc.; 2013. Available at: http://www.accessdata.fda.gov/drugsatfda-docs/label/ 2013/022430s004lbl.pdf. Retrieved March 31, 2014.
31. Aksu F, Madazli R, Budak E, Cepni I, Benian A. High-dose medroxyprogesterone acetate for the treatment of dysfunctional uterine bleeding in 24 adolescents. Aust N Z J Obstet Gynaecol 1997;37:228-31. [PubMed]
32. Munro MG, Mainor N, Basu R, Brisinger M, Barreda L. Oral medroxyprogesterone acetate and combination oral contraceptives for acute uterine bleeding: a randomized controlled trial. Obstet Gynecol 2006;108:924-9. [PubMed] [Obstetrics & Gynecology]
33. Management of acute abnormal uterine bleeding in nonpregnant reproductive-aged women. Committee Opinion No. 557. American College of Obstetricians and Gynecologists. Obstet Gynecol 2013;121:891-6. [PubMed] [Obstetrics & Gynecology]
34. Alperin M, Quaas A, Johnson NR, Hornstein MD. Endometrial ablation in a woman with a persistent uterine hemorrhage due to acute promyelocytic leukemia: a case report. J Reprod Med 2007;52:548-50. [PubMed]